4-Bromo-1,2-dihydro-3H-indazol-3-one(CAS: 864845-15-8)

4-Bromo-1,2-dihydro-3H-indazol-3-one (CAS: 864845-15-8) is regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations for substances produced or imported in the EU, and may be subject to FDA and EPA requirements for registration and handling in the US. These guidelines cover health, environmental, and physical hazards, as well as safety data sheets and labels.

While 4-Bromo-1,2-dihydro-3H-indazol-3-one (CAS: 864845-15-8) is a specific compound, its synthesis can be approached using various bromination techniques or by synthesizing similar substituted indazoles. Common alternatives include indazole derivatives with different substituents, which can be synthesized using related reagents and methods.

The market for 4-Bromo-1,2-dihydro-3H-indazol-3-one (CAS: 864845-15-8) is driven by its applications in pharmaceuticals and fine chemicals. Research trends focus on its use as an intermediate in drug development and as a building block for complex organic molecules. Emerging trends include its potential in anti-inflammatory and anticancer treatments.

Waste containing 4-Bromo-1,2-dihydro-3H-indazol-3-one (CAS: 864845-15-8) should be collected in compatible containers, labeled with the appropriate hazard symbols, and stored separately from incompatible materials. It should be disposed of via incineration or through a professional waste disposal service that adheres to local regulations. Environmental protection measures include ensuring proper containment to prevent leaks and spills.